Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 333

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication rates

Houben, Beek, D. Van De, Hensen, Craen, A. J. M. De, Rauws, Tytgat·1999·Alimentary Pharmacology & Therapeutics

Abstract

Background: : We systematically reviewed all available data in the literature to determine the overall eradication rates of currently advised Helicobacter pylori eradication regimens and to resolve conflicting evidence on the impact of antimicrobial resistance on the eradication rates. Methods: : A comprehensive search of all published trials on H. pylori eradication therapy was carried out via an electronic database search, hand‐searching and checking reference lists of pharmaceutical companies and other reviews. Full papers and abstracts in the English language which study currently advised eradication regimes were included. Results: : 770 study‐arms were analysed. Mean eradication rates for bismuth based triple, proton pump inhibitor triple, quadruple and ranitidine bismuth citrate combination therapies vary from 65 to 92%. In case of nitroimidazole resistance, a drop in efficacy of up to 50% was found for bismuth‐based triple and proton pump inhibitor‐based triple therapies. For quadruple therapy, a significant difference in efficacy was found in the equal‐effects analysis; however, this could not be confirmed in the random‐effects analysis. In case of clarithromycin resistance, a mean drop in efficacy of 56% was found for one‐ and two‐week clarithromycin containing proton pump inhibitor‐triple therapies and of 58% for two‐week ranitidine bismuth citrate combined with clarithromycin therapies. For ranitidine bismuth citrate combined with clarithromycin and nitroimidazole, no difference in efficacy was found in case of nitroimidazole or clarithromycin resistance, but data are still scarce. Conclusions: : The cure rate with most regimens dropped significantly, in case of nitroimidazole‐resistant strains, compared to nitroimidazole‐susceptible strains. In case of clarithromycin resistance, the efficacy of most regimens is also decreased; however, data are still scarce. These data should allow physicians to make a better choice of an appropriate therapy for their patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2036.1999.00555.x

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 333

Metadata

Authors
Houben, Beek, D. V. D., Hensen, Craen, A. J. M. D., Rauws, & Tytgat
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
1999-08
Volume
13
Issue
8
Pages
1047-1055
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2134300124
Cited by
333
References
14
FWCI
5.03
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication rates. https://app.cochat.ai/papers/10.1046/j.1365-2036.1999.00555.x
The paper
Houben, Beek, D. V. D., Hensen, Craen, A. J. M. D., Rauws, & Tytgat. (1999). A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication rates. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.1999.00555.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.